Kathleen Goin sold $474K of Palvella Therapeutics (PVLA)

Executed Jun 17, disclosed Jun 22, 5 days later.

Value, as filed

$474K

4,277 sh across 2 lots

Executed

Jun 17

the trade date, as filed

Disclosed

Jun 22

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Kathleen Goin Chief Operating Officer profile →

Kathleen Goin (Chief Operating Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Palvella Therapeutics, Inc. (PVLA). The largest single filing was $655K of PVLA (4,302 sh across 3 lots, as filed), executed Sep 16.

The name

PVLA

Palvella Therapeutics, Inc. PVLA · Healthcare · 14 filings in 24 months ticker →

Healthcare · Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kathleen Goin in PVLA

PVLASALE Palvella Therapeutics, Inc. $655K
4,302 sh across 3 lots
Exec Sep 16
Filed Sep 18 · 4:05 PM ET PVLASALE Palvella Therapeutics, Inc. $530K
3,498 sh across 2 lots
Exec Aug 19
Filed Aug 20 · 4:05 PM ET PVLASALE Palvella Therapeutics, Inc. $565K
3,780 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 4:05 PM ET PVLASALE Palvella Therapeutics, Inc. $371K
3,363 sh × $110.35
Exec May 20
Filed May 22 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. $380K
3,002 sh across 2 lots
Exec Apr 15
Filed Apr 17 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. $471K
3,998 sh across 2 lots
Exec Mar 18
Filed Mar 20 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. $342K
4,302 sh across 2 lots
Exec Feb 18
Filed Feb 20 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. $367K
3,749 sh × $97.94
Exec Jan 21
Filed Jan 23 · 5:30 PM ET